Atlas Trials

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Clinical trial NCT06473948 · UNKNOWN

Trial details

NCT number
NCT06473948
Sponsor
Jemincare
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor, Adult
Start date
2024-07-10
Primary completion
2024-09-24
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.